Skip to main content Skip to main navigation menu Skip to site footer

Association between Human Papilloma Virus (HPV) genotype and protein of retinoblastoma expression in cervical cancer

  • Nadia Kurnia Wardani Rauf ,
  • Sharvianty Arifuddin ,
  • Elizabet Catherine Jusuf ,
  • Muhammad Husni Cangara ,
  • Firdaus Hamid ,
  • Nugraha Utama Pelupessy ,
  • Irnawaty Bahar ,


Abstract

Link of Video Abstract: https://youtu.be/5Q9QmV4Qmyg

 

Background: Regarding prevalence among females worldwide, cervical cancer ranks fourth and has a high fatality rate. Cervical cancer growth is correlated with high-risk human papillomavirus (HPV) infection. Retinoblastoma protein (pRb) is a protein that interacts with E6/E7 oncoproteins to regulate cell proliferation, differentiation, and death. Mutations on the E6/E7 protein oncogenes of high-risk HPV can disrupt this relationship. This investigation aims to establish the association between pRb expression and the HPV genotype.

Methods: This observational cross-sectional study examined 43 patients diagnosed with cervical cancer at Wahidin Sudirohusodo Hospital and its network. Samples were taken using consecutive random sampling based on established criteria. HPV genotype was examined using the polymerase chain reaction (PCR) method, while pRB expression was assessed by immunohistochemical examination. The relationship between the two variables was assessed using the Chi-Square test.

Results:  There were 5 (11.6%) patients with HPV type 16, 14 (32.6%) with HPV type 18, 12 (27.9%) with other types of HPV and 12 (27.9%) were negative for HPV. Examination of pRb expression showed that 33 (76.7%) samples had +2 expression, 7 (16.3%) had +1 expression, and 3 (7.0%) samples had no pRb expression. The pRb expression and HPV type were not significantly correlated in this study (p = 0.410). However, pRb expression and cervical cancer clinical stage were shown to be significantly correlated (p = 0.007).

Conclusion: pRb expression is more prevalent when a malignancy is more advanced. In this investigation, no association between HPV genotype and pRb expression was discovered, despite oncogene mutations being involved in the regulation mechanism of cell proliferation, differentiation, and apoptosis.

Keywords: Cervical cancer HPV Neoplasm Protein of Retinoblastoma

References

  1. Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key Molecular Events in Cervical Cancer Development. Med Kaunas Lith. 2019;55(7):384.
  2. ICO/IARC HPV Information Center. Indonesian: Human Papillomavirus and Related Cancers, Fact Sheet 2023. Published online 2023. Available at: https://hpvcentre.net/statistics/reports/IDN_FS.pdf. Accessed on: 3rd March 2023.
  3. Zhu X, Wang Y, Lv Z, Su J. Prevalence and genotype distribution of high‐risk HPV infection among women in Beijing, China. J Med Virol. 2021;93(8):5103-5109.
  4. Martin CM, Kehoe L, Spillane CO, O’Leary JJ. Gene Discovery in Cervical Cancer: Towards Diagnostic and Therapeutic Biomarkers. Mol Diagn Ther. 2007;11(5):277-290.
  5. Mahendra INB, Fani E, Budiana ING, Megadhana IW, Aryana MBD, Winata IGS. Correlation Between E6 and E7 Oncogene Mutation Human Papilloma Virus High-Risk Type 16 with Retinoblastoma Protein Expression in Cervical Cancer. Eur J Med Health Sci. 2022;4(6):65-70.
  6. Burmeister CA, Khan SF, Schäfer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Res. 2022;13(1):200238.
  7. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006;25(38):5220-5227.
  8. Al-shuwaikh AMA, Latif I. Immunohistochemical Study of Retinoblastoma Protein (Prb) Expression in Cervical Carcinomas and Their Premalignant Lesions. Tumor Mol Virol. Published online 2010;6(3):68-76.
  9. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143(1):22-36.
  10. Campion MJ, Canfell K. Berek & Hacker’s Gynecologic Oncology. 2015:326-380.
  11. Aziz H, Sattar AA, Mahmood H, Fatima S, Khurshid M, Faheem M. Prevalence of HPV types in HIV-positive and negative females with normal cervical cytology or dysplasia. J Clin Lab Anal. 2023;37(4):e24851.
  12. Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009;100(7):1191-1197.
  13. del Refugio González-Losa M, Laviada Mier y Teran MA, Puerto-Solís M, García-Carrancá A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2004;29(2):95-98.
  14. Wang D, Zhao C, Fu L, Liu Y, Zhang W, Xu T. Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol. Obstet Gynecol Int. 2019;2019(1):1-6.
  15. Muñoz JP, Carrillo-Beltrán D, Aedo-Aguilera V, Calaf GM, León O, Maldonado E, et al. Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells. Front Microbiol. 2018;9(1):3022.
  16. Bourgo RJ, Braden WA, Wells SI, Knudsen ES. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines. Mol Carcinog. 2009;48(1):45-55.
  17. Herlana F, Nur IM, Purbaningsih W. Characteristics of Cervical Cancer Patients based on Age, Parity, and Histopathological Features at Al-Ihsan Hospital Bandung. Bdg Meet Glob Med Health BaMGMH. 2017;1(1):138-142.
  18. Itarat Y, Kietpeerakool C, Jampathong N, Chumworathayi B, Kleebkaow P, Aue-Aungkul A, et al. Sexual behavior and infection with cervical human papillomavirus types 16 and 18. Int J Womens Health. 2019;11(1):489-494.
  19. Kim S, Arduino JM, Roberts CC, Marsico M, Liaw KL, Skjeldestad FE. Incidence and Predictors of Human Papillomavirus-6, -11, -16, and -18 Infection in Young Norwegian Women. Sex Transm Dis. 2011;38(7):587-597.
  20. Mahendra INB. Low molecular mass polypeptide and transporter antigen peptide genes polymorphism as the risk factors of cervical cancer caused by human papillomavirus type-16 infection in Bali. Bali Medical Journal. 2015;4(3):143–147.
  21. Kovacevic G, Milosevic V, Nikolic N, Patic A, Dopudj N, Radovanov J, et al. The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia. Angeletti PC, ed. PLOS ONE. 2021;16(4):e0249134.
  22. Hernández-Rosas F, Orozco-Hernández E, Maza-Sánchez L, Salgado-García PC, Navarro-Vidal E, León-Bautista MPD. Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women. Exp Biol Med. 2021;246(1):48-56.
  23. Kaliff M, Sorbe B, Mordhorst LB, Helenius G, Karlsson MG, Lillsunde-Larsson G. Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy. Oncotarget. 2018;9(27):18786-18796.
  24. Gadducci A, Cosio S, Fruzzetti F. Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue. Anticancer Res. 2020;40(11):5995-6002.
  25. Muñoz JP, Carrillo-Beltrán D, Aedo-Aguilera V, Calaf GM, Leon O, Maldonado E, et al. Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells. Front Microbiol. 2018;9(1):3022.
  26. Buitrago-Perez A, Garaulet G, Vazquez-Carballo A, Paramio J, Garcia-Escudero R. Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling. Curr Genomics. 2009;10(1):26-34.
  27. Dey B. Immunohistochemical Analysis of P53 and PRB in Esophageal Squamous Cell Carcinoma. J Clin Diagn Res. 2014:8(5):FC01.
  28. Meijer CJLM, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124(3):516-520.
  29. Cangara MH, Wibowo AP, Miskad UA, Nelwan B, Masadah R, Rauf S, et al. Detection of human papillomavirus (HPV) in paraffin block of cervical cancer patients using multiplex polymerase chain reaction (PCR) and reverse line blot methods. Med Clínica Práctica. 2021;4(1):100225.
  30. Xing B, Guo J, Sheng Y, Wu G, Zhao Y. Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review. Front Oncol. 2021;10(1):606335.
  31. Stolnicu S, Hoang L, Zhou Q, Iasonos A, Terinte C, Pesci A, et al. Cervical Adenosquamous Carcinoma: Detailed Analysis of Morphology, Immunohistochemical Profile, and Outcome in 59 Cases. Int J Gynecol Pathol. 2022;42(3):259-269.
  32. Al-Shuwaikh A, Latif I. Immunohistochemical Study of Retinoblastoma Protein (Prb) Expression in Cervical Carcinomas and Their Premalignant Lesions. Diyala J Pure Sci. 2010;6(3):68-76.
  33. Mahendra INB, Fani E, Budiana ING, Megadhana IW, Aryana MBD, Winata IGS. Correlation Between E6 and E7 Oncogene Mutation Human Papilloma Virus High-Risk Type 16 with Retinoblastoma Protein Expression in Cervical Cancer. Eur J Med Health Sci. 2022;4(6):65-70.
  34. Oh KJ, Kalinina A, Bagchi S. Destabilization of Rb by human papillomavirus E7 is cell cycle-dependent: E2-25K is involved in the proteolysis. Virology. 2010;396(1):118-124.
  35. Mandigo AC, Tomlins SA, Kelly WK, Knudsen KE. Relevance of pRB Loss in Human Malignancies. Clin Cancer Res Off J Am Assoc Cancer Res. 2022;28(2):255-264.
  36. Uyeda M, Subramanian M. Screening and Identification of New Biomarkers for the Control of Cervical Cancer. MEDICINE & PHARMACOLOGY. 2020.
  37. Prabawa IPY, Bhargah A, Liwang F, Tandio DA, Tandio AL, Lestari AAW, et al. Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive value of hematological markers in cervical cancer. Asian Pacific journal of cancer prevention: APJCP. 2019;20(3):863.
  38. Parwanto E, Wratsangka R, Guyansyah A, Anggraeni K, Digambiro RA, Tjahyadi D, et al. The change of cell biometric and its nucleus on cervical-squamous-epithelial-cell with GA genotype of Fas-promoter-670 gene, high-risk human papillomavirus and Candida species infection: a case report. Bali Medical Journal. 2021;10(1):74–81.
  39. Wasita B, Suyatmi, Pesik RN, Yudhani RD, Wiyono N, Rahayu RF, et al. High-risk human papillomavirus prevalence among patients with cervical cancer at Moewardi General Hospital in Surakarta, Indonesia. Bali Medical Journal. 2023;12(2),1918–1921.

How to Cite

Rauf, N. K. W., Arifuddin, S., Jusuf, E. C., Cangara, M. H., Hamid, F., Pelupessy, N. U., & Bahar, I. (2023). Association between Human Papilloma Virus (HPV) genotype and protein of retinoblastoma expression in cervical cancer. Bali Medical Journal, 12(3), 2707–2714. https://doi.org/10.15562/bmj.v12i3.4662
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Nadia Kurnia Wardani Rauf
Google Scholar
Pubmed
BMJ Journal

Sharvianty Arifuddin
Google Scholar
Pubmed
BMJ Journal

Elizabet Catherine Jusuf
Google Scholar
Pubmed
BMJ Journal

Muhammad Husni Cangara
Google Scholar
Pubmed
BMJ Journal

Firdaus Hamid
Google Scholar
Pubmed
BMJ Journal

Nugraha Utama Pelupessy
Google Scholar
Pubmed
BMJ Journal

Irnawaty Bahar
Google Scholar
Pubmed
BMJ Journal